| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260804.2 |
Tanespimycin |
Chronic Lymphocytic Leukemia |
0.006257832 |
Resistant |
| ENSG00000260804.2 |
Tanespimycin |
Sarcoma |
0.041662431 |
Resistant |
| ENSG00000260804.2 |
Tanespimycin |
Colon adenocarcinoma |
0.021625035 |
Sensitive |
